翻訳と辞書 Words near each other ・ Oxalate CoA-transferase ・ Oxalate decarboxylase ・ Oxalate oxidase ・ Oxalate oxidoreductase ・ Oxalate—CoA ligase ・ Oxalic acid ・ Oxalic anhydride ・ Oxalicibacterium ・ Oxalicibacterium faecigallinarum ・ Oxalicibacterium flavum ・ Oxalicibacterium horti ・ Oxalicibacterium solurbis ・ Oxalidaceae ・ Oxalidales ・ Oxaline ・ Oxaliplatin ・ Oxalis ・ Oxalis (disambiguation) ・ Oxalis acetosella ・ Oxalis adenophylla ・ Oxalis albicans ・ Oxalis articulata ・ Oxalis ausensis ・ Oxalis barrelieri ・ Oxalis bowiei ・ Oxalis caerulea ・ Oxalis caprina ・ Oxalis corniculata ・ Oxalis debilis ・ Oxalis dehradunensis Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Oxaliplatin ： ウィキペディア英語版 Oxaliplatin Oxaliplatin, marketed as Eloxatin by Sanofi, is a platinum-based antineoplastic agent used in cancer chemotherapy. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system. ==History== Oxaliplatin was discovered in 1976 at Nagoya City University by Professor Yoshinori Kidani, who was granted U.S. Patent 4,169,846 in 1979. Oxaliplatin was subsequently in-licensed by Debiopharm and developed as an advanced colorectal cancer treatment. Debio licensed the drug to Sanofi-Aventis in 1994. It gained European approval in 1996 (initially in France) and approval by the U.S. Food and Drug Administration in 2002. Generic oxaliplatin was first approved in the United States in August 2009.〔(【引用サイトリンク】 title=Generic Eloxatin availability )〕 Patent disputes caused generic production to stop in 2010, but it restarted in 2012.〔http://www.prnewswire.com/news-releases/hospira-announces-us-re-launch-of-generic-oxaliplatin-injection-165568176.html〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Oxaliplatin」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.